Concepedia

BETH R. FROMMER

BR

8

Publications

618

Citations

8

H-Index

1986

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

DuPont (United States)

BETH R. FROMMER is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, microbiology, and natural sciences.

Top concepts

Publications per year

1986–1997

8

Publications

8

The Discovery of Australifungin, a Novel Inhibitor of Sphinganine N-Acyltransferase from Sporormiella australis. Producing Organism, Fermentation, Isolation, and Biological Activity.

Suzanne Mandala, Rosemary Thornton, BETH R. FROMMER et al. · The Journal of Antibiotics · 1995 · 188 citations · Full text

Sphingofungins F and F: Novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii.

Wendy S. Horn, Jack L. Smith, Gerald F. Bills et al. · The Journal of Antibiotics · 1992 · 123 citations · Full text

, , +10

Inhibition of serine palmitoyl-transferase activity by lipoxamycin.

Suzanne Mandala, BETH R. FROMMER, Rosemary Thornton et al. · The Journal of Antibiotics · 1994 · 87 citations · Full text

, , +6

Bacteriophage P1 Cre-loxP site-specific recombination. Site-specific DNA topoisomerase activity of the Cre recombination protein.

Ken Abremski, Anna Wierzbicki, BETH R. FROMMER et al. · Journal of Biological Chemistry · 1986 · 78 citations · Full text

, , +15

Viridiofungins, Novel Inhibitors of Sphingolipid Synthesis.

Suzanne Mandala, Rosemary Thornton, BETH R. FROMMER et al. · The Journal of Antibiotics · 1997 · 78 citations · Full text

Rows per page

1–5 of 8